| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |